A Prospective Open‐Label Observational Study of a Buffered Soluble 70 mg Alendronate Effervescent Tablet on Upper Gastrointestinal Safety and Medication Errors: The GastroPASS Study

Upper gastrointestinal (GI) side effects are a main reason for discontinuing bisphosphonate treatment, an important therapeutic option for osteoporosis patients. Consequently, the development of novel formulations with improved tolerability is warranted. In this multicenter prospective, observationa...

Descripción completa

Detalles Bibliográficos
Autores principales: Minisola, Salvatore, Vargas, Antonio P, Letizia Mauro, Giulia, Bonet Madurga, Fernando, Adami, Giovanni, Black, Dennis M, Qizilbash, Nawab, Blanch‐Rubió, Josep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260812/
https://www.ncbi.nlm.nih.gov/pubmed/34258506
http://dx.doi.org/10.1002/jbm4.10510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260812/
https://www.ncbi.nlm.nih.gov/pubmed/34258506
http://dx.doi.org/10.1002/jbm4.10510

Ejemplares similares